Beilstein Journal of Nanotechnology,
Journal Year:
2024,
Volume and Issue:
15, P. 1619 - 1626
Published: Dec. 16, 2024
Biomimetic
nanocarriers,
engineered
to
mimic
the
characteristics
of
native
cells,
offer
a
revolutionary
approach
in
treatment
various
complex
human
diseases.
This
strategy
enhances
drug
delivery
by
leveraging
innate
properties
cellular
components,
thereby
improving
biocompatibility
and
targeting
specificity.
nanocarriers
demonstrate
significant
advancements
systems
against
cancer
therapy,
Alzheimer's
disease,
autoimmune
diseases,
viral
infections
such
as
COVID-19.
Here,
we
address
therapeutic
applications
biomimetic
their
promising
for
personalized
medicine.
Journal of Nanoparticle Research,
Journal Year:
2024,
Volume and Issue:
26(8)
Published: Aug. 1, 2024
Abstract
Glioblastoma
(GBM),
the
most
prevalent
primary
brain
tumor
in
adults,
remains
highly
challenging
due
to
its
invasive
nature,
limited
treatment
effectiveness,
and
short
median
survival
durations.
Standard
of
care
includes
surgery,
radiation,
chemotherapy,
treating
fields;
however,
there
has
been
little
improvement
rates.
Biomimetic
nanoparticles
(NPs),
coated
with
cell
membranes
endogenous
components,
have
immense
potential
for
improving
chemotherapy
GBM,
by
imitating
cellular
architecture
eluding
immune
clearance.
With
more
individualized
efficient
drug
delivery,
immunotherapeutic
approaches
biomimetic
NPs
may
increase
patient
This
article
summarizes
main
research
on
GBM
therapy,
focusing
classification,
mechanisms,
advantages,
challenges,
along
advancements
development
vaccines.
Journal of Dispersion Science and Technology,
Journal Year:
2023,
Volume and Issue:
45(7), P. 1351 - 1363
Published: May 21, 2023
Breast
cancer
is
one
of
the
leading
cause
death
in
women
all
around
world.
Several
strategies
are
utilized
for
treatment
breast
&
its
types.
Nanotechnology
gaining
interest
due
to
advantage
nano
size,
variety
carriers,
suitable
hydrophobic
drug
loading,
controlled
and
site-specific
delivery.
Because
reproducible
synthesis
features
like
shape,
ease
surface
modification,
nanoparticles
frequently
chosen.
Further,
certain
allow
adjuvant
therapy,
which
results
a
synergistic
therapeutic
outcome.
Such
nanoparticles,
however,
detected
by
immune
system
eliminated
from
circulation.
Cellular
membranes
have
been
studied
extensively
as
potential
alternatives
augmenting
anticancer
treatments'
biocompatibility
targeting
abilities.
Red
blood
cells
(RBCs),
cells,
platelets,
other
identified
sources
reported
membrane-coated
delivery
systems.
Each
membrane's
distinct
ability
target
tumors
biomarkers
exploited.
Thus,
inspired
nature
cell
used
camouflage
circulation
improve
retention
time
tumor
ability.
These
membrane
cloaked
NPs
(CMCNPs)
therefore
being
researched
theranoustic,
photothermal
therapy
vaccine
development
cancer.
Here,
we
covered
crucial
procedures
significant
problems
involved
characterization
CMCNPs.
This
thorough
overview
modified
CMCNPs
discusses
cloaking
techniques,
well
prospects
limitations
clinical
use
Interdisciplinary cancer research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Pediatric
bone
sarcomas
are
rare
and
aggressive
cancers
that
pose
significant
treatment
challenges.
Traditional
chemotherapy
surgery
have
limitations
in
achieving
complete
remission,
especially
cases
of
metastatic
disease.
Nanodrug
delivery
systems
offer
a
promising
approach
to
overcome
these
by
delivering
therapeutic
agents
directly
the
tumor
site
with
increased
efficacy
reduced
toxicity.
In
this
chapter,
we
discuss
recent
advances
use
nanodrug
pediatric
sarcomas,
covering
organic
nanoparticles
(NPs),
including
liposomes,
polymeric
NPs,
micelles,
dendrimers
as
well
inorganic
NPs.
We
also
highlight
potential
combining
other
therapies,
such
immunotherapy
gene
therapy,
enhance
outcomes.
Overall,
holds
great
promise
for
improving
sarcoma
outcomes
patients.
Beilstein Journal of Nanotechnology,
Journal Year:
2024,
Volume and Issue:
15, P. 1619 - 1626
Published: Dec. 16, 2024
Biomimetic
nanocarriers,
engineered
to
mimic
the
characteristics
of
native
cells,
offer
a
revolutionary
approach
in
treatment
various
complex
human
diseases.
This
strategy
enhances
drug
delivery
by
leveraging
innate
properties
cellular
components,
thereby
improving
biocompatibility
and
targeting
specificity.
nanocarriers
demonstrate
significant
advancements
systems
against
cancer
therapy,
Alzheimer's
disease,
autoimmune
diseases,
viral
infections
such
as
COVID-19.
Here,
we
address
therapeutic
applications
biomimetic
their
promising
for
personalized
medicine.
